Megan Mariko Perron

Megan Mariko Perron

Auto-generated profile, based on publicly available information

Megan Mariko Perron

Division of Immunology Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2021 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
MPMegan Mariko Perron
Megan Mariko Perron
NVNatalia Vasquez-Canizares
Natalia Vasquez-Canizares
GTGabriel Tarshish
Gabriel Tarshish
DWDawn M. Wahezi
Dawn M. Wahezi
Background: Juvenile idiopathic inflammatory myopathies (JIIMs) is a group of autoimmune disorders, including juvenile dermatomyositis (JDM), juvenile polymyositis (JPM) and overlap myositis, that are characterized by proximal muscle weakness, elevated levels of serum muscle enzymes, and pathognomonic skin findings. While the exact etiology of JIIMs is unclear, the presence of myositis specific autoantibodies (MSAs) have been associated with certain clinical phenotypes, organ involvement and disease prognosis. To date, there have been few studies of the associations between MSA presence and patient ethnicity. It is important to understand the extent to which ethnicity impacts disease manifestations, organ involvement and clinical outcomes. The goal of our study is to determine MSA and myositis associated autoantibody (MAA) presence, clinical phenotype, and disease course in a racially diverse population of pediatric patients with JIIMs. Methods: Patients age 2–21 years with a prior diagnosis of JDM, JPM or overlap myositis, who had been tested for MSA/MAA, were eligible for study inclusion. Clinical and laboratory data were collected retrospectively via manual chart review in this single-center study. Descriptive statistics were performed to summarize each variable. Given the small sample size, non-parametric testing was performed using Fischer’s exact test, Wilcoxon rank sum test and Kruskal-Wallis test. Results: Thirty one patients were included in the analysis. Race and ethnicity were self-reported as Hispanic (48.4%), white (25.8%), and Black (25.8%). The most prevalent MSAs were anti-MDA5 (25.8%), anti-p155/140 (22.6%) and anti-MJ (19.4%). Presence of autoantibodies (p = 0.04) and pulmonary disease (p = 0.03) were significantly higher in patients of Black or Hispanic descent compared with white descent. Anti-MDA5 antibodies, cutaneous ulceration, cardiopulmonary involvement, hospitalizations and one death were only reported in patients with Black or Hispanic descent. Patients with anti-MDA5 antibodies were more likely to be male (p = 0.04) and to have cutaneous ulceration (p = 0.02). Conclusions: This study describes the prevalence of MSA/MAA in a racially diverse group of patients with JIIM and further delineates clinical phenotype and disease complications in these groups. We found a relatively high proportion of children with anti-MDA5 antibodies and described potentially worse clinical courses in children of Black or Hispanic descent. Further investigation is warranted to examine these findings.

14 August 2024 in Arthritis Care & Research
Verified
Journal Article
Closed access
STStacey E. Tarvin
Stacey E. Tarvin
MSMatthew A. Sherman
Matthew A. Sherman
HKHanna Kim
Hanna Kim
NBNayimisha Balmuri
Nayimisha Balmuri
ABAmanda G. Brown
Amanda G. Brown
FWfor the Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup
for the Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup

7 May 2024 in Arthritis Care & Research
Verified
Journal Article
Closed access
MPMegan Mariko Perron
Megan Mariko Perron
SZSonja I Ziniel
Sonja I Ziniel
MCMegan Curran
Megan Curran
JBJessica L Bloom
Jessica L Bloom
PVPatricia Vega-Fernandez
Patricia Vega-Fernandez
CLClara Lin
Clara Lin

8 December 2024
Verified
Book Chapter
Closed access
MPMegan Mariko Perron
Megan Mariko Perron
JCJennifer C. Cooper
Jennifer C. Cooper
JLJerome C. Lane
Jerome C. Lane

17 July 2025 in Pediatric Dermatology
Verified
Journal Article
Closed access
RBRacquel A. Bitar
Racquel A. Bitar
SSSarah E. Servattalab
Sarah E. Servattalab
LHLauren A. Henderson
Lauren A. Henderson
MPMegan M. Perron
Megan M. Perron
ATAmir H. Taghinia
Amir H. Taghinia
MLMarilyn G. Liang
Marilyn G. Liang